1. Home
  2. UWMC vs CBLL Comparison

UWMC vs CBLL Comparison

Compare UWMC & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UWMC
  • CBLL
  • Stock Information
  • Founded
  • UWMC 1986
  • CBLL 2014
  • Country
  • UWMC United States
  • CBLL United States
  • Employees
  • UWMC N/A
  • CBLL N/A
  • Industry
  • UWMC Finance: Consumer Services
  • CBLL
  • Sector
  • UWMC Finance
  • CBLL
  • Exchange
  • UWMC Nasdaq
  • CBLL Nasdaq
  • Market Cap
  • UWMC 911.2M
  • CBLL 927.1M
  • IPO Year
  • UWMC N/A
  • CBLL 2024
  • Fundamental
  • Price
  • UWMC $6.22
  • CBLL $22.94
  • Analyst Decision
  • UWMC Hold
  • CBLL Strong Buy
  • Analyst Count
  • UWMC 8
  • CBLL 5
  • Target Price
  • UWMC $7.34
  • CBLL $33.25
  • AVG Volume (30 Days)
  • UWMC 4.1M
  • CBLL 304.8K
  • Earning Date
  • UWMC 02-26-2025
  • CBLL 02-14-2025
  • Dividend Yield
  • UWMC 6.43%
  • CBLL N/A
  • EPS Growth
  • UWMC N/A
  • CBLL N/A
  • EPS
  • UWMC N/A
  • CBLL N/A
  • Revenue
  • UWMC $2,727,467,000.00
  • CBLL $60,041,000.00
  • Revenue This Year
  • UWMC $3.72
  • CBLL $44.86
  • Revenue Next Year
  • UWMC $24.09
  • CBLL $26.56
  • P/E Ratio
  • UWMC N/A
  • CBLL N/A
  • Revenue Growth
  • UWMC 29.95
  • CBLL 131.62
  • 52 Week Low
  • UWMC $5.31
  • CBLL $18.69
  • 52 Week High
  • UWMC $9.74
  • CBLL $32.75
  • Technical
  • Relative Strength Index (RSI)
  • UWMC 57.97
  • CBLL N/A
  • Support Level
  • UWMC $5.31
  • CBLL N/A
  • Resistance Level
  • UWMC $6.28
  • CBLL N/A
  • Average True Range (ATR)
  • UWMC 0.27
  • CBLL 0.00
  • MACD
  • UWMC 0.09
  • CBLL 0.00
  • Stochastic Oscillator
  • UWMC 93.31
  • CBLL 0.00

About UWMC UWM Holdings Corporation

UWM Holdings Corp engages in the origination, sale and servicing of residential mortgage loans. The company provides independent mortgage advisors across the states and the district of Columbia.

About CBLL CeriBell Inc. Common Stock

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: